Comparison |
| Alternate Manufacturer Number |
3782919 | 1207182 | | | |
| Container Type |
Bottle | Bottle | Bottle | Single Dose Vial Kit | Single Dose Vial Kit |
| Dosage Form |
Tablet | Tablet | Solution | Injection | Injection |
| Generic Drug Code |
| 23152 | 31782 | | |
| Generic Drug Name |
Lamivudine | Emtricitabine / Tenofovir Disoproxil Fumarate | Lopinavir / Ritonavir | Cabotegravir / Rilpivirine | Cabotegravir / Rilpivirine |
| NDC Number |
65862002560 | 61958070101 | 00074395646 | 49702024015 | 49702025315 |
| Storage Requirements |
| | Requires Refrigeration | Requires Refrigeration | Requires Refrigeration |
| Strength |
150 mg | 200 mg - 300 mg | 400 mg - 100 mg / 5 mL | 600 mg - 900 mg | 400 mg - 600 mg |
| Type |
| Film Coated | Oral | Intramuscular | Intramuscular |
| UNSPSC Code |
51343110 | 51343804 | 51343111 | 51343800 | 51343800 |
| Volume |
60 Tablets | 30 Tablets | 160 mL | | |
| Application |
Antiretroviral | Antiretroviral | Antiretroviral | Antiretroviral | Antiretroviral |
| Country of Origin |
Unknown | Unknown | Unknown | Unknown | Unknown |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Features and Benefits |
|
|
- Cotton Candy - Mint flavor
|
- CABENUVA is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine
- Requires Refrigeration
- Intramuscular (IM) gluteal
|
- CABENUVA is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine
- Requires Refrigeration
- Intramuscular (IM) gluteal
|
